Tom 12, Nr 6 (2017)
FORUM PRZYPADKÓW KLINICZNYCH
Opublikowany online: 2018-02-05
Wyświetlenia strony
385
Wyświetlenia/pobrania artykułu
955
Zakrzepica w stencie bioresorbowalnym (BVS). Czy to zmierzch technologii, czy czas na refleksję?
Kardiol Inwazyjna 2017;12(6):35-41.
Streszczenie
W bieżącym numerze przedstawiamy zakrzepicę w stencie bioresorbowalnym (BVS) która zmusza do analizy dwóch bardzo ważnych aspektów: techniki zabiegu implantacji stentów BVS oraz samej technologii i jej przyszłości.
Słowa kluczowe: stent bioabsorbowalnyzakrzepica w stencie
Referencje
- Puricel S, Cuculi F, Weissner M, et al. Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors. J Am Coll Cardiol. 2016; 67(8): 921–931.
- Ellis SG, Kereiakes DJ, Metzger DC, et al. ABSORB III Investigators. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med. 2015; 373(20): 1905–1915.
- Felix CM, Vlachojannis GJ, IJsselmuiden AJJ, et al. Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. EuroIntervention. 2017; 13(2): e177–e184.
- Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979; 301(2): 61–68.
- Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987; 316(12): 701–706.
- Stone G. Impact of technique on early and late outcomes following coronary bioresorbable scaf-fold implantation: analysis from the ABSORB trials. Paper presented at: CRT17; Washington, DC, February 18–21, 2017.
- Kereiakes DJ. New Randomized Trial Data (1-Year Outcomes): ABSORB III (TCT Late-Breaking Clinical Trial Results and Beyond). Transcatheter Cardiovascular Therapeutics 2015. http://www.tctmd. com/show.aspx?id=398&ref_id=132165.
- Bangalore S, Bezerra HG, Rizik DG, et al. The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel. JACC Cardiovasc Interv. 2017; 10(23): 2349–2359.
- Gori T, Weissner M, Gönner S, et al. Characteristics, predictors, and mechanisms of thrombosis in coronary bioresorbable scaffolds differences between early and late events. JACC Cardiovasc Interv. 2017; 10(23): 2363–2371.
